Used in neuroscience and Alzheimer’s disease research to quantify levels of amyloid beta 1-40 peptide in biological samples such as cerebrospinal fluid, plasma, and cell culture supernatants. Enables researchers to monitor amyloid plaque formation, a hallmark of Alzheimer’s pathology, and assess the effectiveness of therapeutic compounds targeting amyloid production or clearance. Widely applied in preclinical studies, drug development, and biomarker validation due to its high sensitivity and specificity for Aβ1-40. Supports investigation into the imbalance between amyloid production and clearance in neurodegenerative disorders.